Ziqian Wang

707 total citations
31 papers, 402 citations indexed

About

Ziqian Wang is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ziqian Wang has authored 31 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 14 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ziqian Wang's work include Systemic Lupus Erythematosus Research (20 papers), Atherosclerosis and Cardiovascular Diseases (12 papers) and Peripheral Neuropathies and Disorders (4 papers). Ziqian Wang is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Atherosclerosis and Cardiovascular Diseases (12 papers) and Peripheral Neuropathies and Disorders (4 papers). Ziqian Wang collaborates with scholars based in China, United States and Argentina. Ziqian Wang's co-authors include Shangzhu Zhang, Jiuliang Zhao, Xinping Tian, Dong Xu, Xiaofeng Zeng, Mengtao Li, Xiaofeng Zeng, Ming Li, Qian Wang and Z. Li and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and Nano Today.

In The Last Decade

Ziqian Wang

27 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziqian Wang China 12 315 157 82 61 44 31 402
Luis Alonso González Colombia 16 412 1.3× 248 1.6× 69 0.8× 85 1.4× 32 0.7× 49 547
Alejandro Alvarellos Argentina 7 400 1.3× 204 1.3× 110 1.3× 77 1.3× 40 0.9× 19 509
Cristina Pamfil Romania 13 348 1.1× 216 1.4× 107 1.3× 61 1.0× 69 1.6× 43 502
Yan Geng China 12 239 0.8× 150 1.0× 61 0.7× 48 0.8× 39 0.9× 46 497
Weng Giap Law Singapore 11 331 1.1× 180 1.1× 110 1.3× 46 0.8× 18 0.4× 16 429
T Y Lian Singapore 7 396 1.3× 223 1.4× 83 1.0× 64 1.0× 34 0.8× 13 459
Sheila Kelly United States 11 400 1.3× 220 1.4× 66 0.8× 62 1.0× 24 0.5× 17 553
Dina Zucchi Italy 14 412 1.3× 252 1.6× 92 1.1× 86 1.4× 24 0.5× 34 517
Hector Arbillaga Canada 9 312 1.0× 165 1.1× 65 0.8× 61 1.0× 69 1.6× 11 344
Luca Iaccarino Italy 11 305 1.0× 154 1.0× 76 0.9× 80 1.3× 28 0.6× 25 423

Countries citing papers authored by Ziqian Wang

Since Specialization
Citations

This map shows the geographic impact of Ziqian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqian Wang more than expected).

Fields of papers citing papers by Ziqian Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqian Wang. The network helps show where Ziqian Wang may publish in the future.

Co-authorship network of co-authors of Ziqian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqian Wang. A scholar is included among the top collaborators of Ziqian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqian Wang. Ziqian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yupeng, Chong Wei, Ziqian Wang, et al.. (2025). Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma. JAMA Dermatology. 161(9). 923–923.
2.
Jiang, Hui, Yangzhong Zhou, Liying Peng, et al.. (2025). Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort. Lupus Science & Medicine. 12(1). e001674–e001674.
3.
Wang, Ziqian, Yujie Ren, Dongmei Zhang, et al.. (2025). Elevated KCa3.1 expression by angiotensin II via the ERK/NF-κB pathway contributes to atrial fibrosis. Journal of Molecular and Cellular Cardiology. 202. 133–143. 1 indexed citations
4.
5.
Chen, Shukun, Chunyan Liu, Yan He, et al.. (2025). Predicting and Validating the Regulation of Podocyte Injury and Treatment of Diabetic Kidney Disease by Yinhuo Tang. Journal of Visualized Experiments. 1 indexed citations
6.
Wang, Ziqian, Jiuliang Zhao, Qian Wang, et al.. (2024). Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI. RMD Open. 10(3). e004425–e004425. 1 indexed citations
7.
Zhang, Hao, Hao Zhang, Wei Li, et al.. (2024). Triple-pathway cGAS-STING activation collaborated with ferroptosis-induced immunogenic cell death for boosting systemic colorectal cancer immunotherapy. Nano Today. 59. 102484–102484. 7 indexed citations
8.
Bai, Wei, Jian Xu, Xinwang Duan, et al.. (2022). Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII. Chinese Medical Journal. 135(18). 2191–2199. 12 indexed citations
9.
Wang, Qian, Ziqian Wang, Shangzhu Zhang, et al.. (2022). Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus. Journal of Clinical Medicine. 11(17). 4955–4955. 12 indexed citations
10.
Wang, Minhui, Ziqian Wang, Shangzhu Zhang, et al.. (2021). Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity Reviews. 21(2). 102996–102996. 5 indexed citations
11.
Zhang, Shangzhu, Meng Li, Li Zhang, et al.. (2021). Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China. Journal of Immunology Research. 2021. 1–10. 25 indexed citations
12.
Wang, Ziqian, Mengtao Li, Zhizhong Ye, et al.. (2021). Long-term outcomes of patients with systemic lupus erythematosus: A Multicenter Cohort Study from CSTAR registry. PubMed. 2(3). 195–202. 15 indexed citations
13.
Shi, Yue, Lingshan Liu, Ziqian Wang, et al.. (2020). Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmunity Reviews. 20(1). 102691–102691. 48 indexed citations
14.
Cheng, Cheng, Ziqian Wang, Li Wang, et al.. (2020). Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis. Clinical Rheumatology. 40(5). 1819–1826. 7 indexed citations
15.
Yang, Ziyi, Cheng Cheng, Ziqian Wang, et al.. (2020). Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care & Research. 74(2). 208–218. 9 indexed citations
16.
Zhang, Shangzhu, Zhen-Nan Ye, Zhijun Li, et al.. (2019). Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes. Lupus. 28(5). 635–641. 12 indexed citations
17.
Peng, Liying, Ziqian Wang, Mengtao Li, et al.. (2017). Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study. Clinical Rheumatology. 36(12). 2727–2732. 9 indexed citations
18.
Li, Z., Dong Xu, Ziqian Wang, et al.. (2017). Gastrointestinal system involvement in systemic lupus erythematosus. Lupus. 26(11). 1127–1138. 60 indexed citations
19.
Wang, Ziqian, Yanhong Wang, Rongrong Zhu, et al.. (2015). Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China. Medicine. 94(17). e794–e794. 79 indexed citations
20.
Zhao, Liwei, Ke Xiao, Ziqian Wang, et al.. (2009). Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. Clinical & Experimental Immunology. 157(2). 310–315. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Alonso González Breakdown of academic impact, for papers by Alejandro Alvarellos Breakdown of academic impact, for papers by Cristina Pamfil Breakdown of academic impact, for papers by Yan Geng Breakdown of academic impact, for papers by Weng Giap Law Breakdown of academic impact, for papers by T Y Lian Breakdown of academic impact, for papers by Sheila Kelly Breakdown of academic impact, for papers by Dina Zucchi Breakdown of academic impact, for papers by Hector Arbillaga Breakdown of academic impact, for papers by Luca Iaccarino
Rankless by CCL
2026